300142 沃森生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资148,664936.49%14,34315,23315,10214,720
投资性房地产22,043-3.81%22,91624,66125,95538,157
固定资产1,730,6560.51%1,721,9521,944,8962,081,6521,599,961
在建工程2,255,704-1.24%2,284,0862,113,8261,645,4161,508,751
无形资产834,2790.34%831,4331,035,1261,085,8871,167,039
商誉33,6580.00%33,65833,65833,65833,658
其他非流动资产1,429,107-45.37%2,615,8692,490,0841,968,0302,025,277
6,454,112-14.22%7,524,2567,657,4836,855,6996,387,564

流动资产
货币资金767,445-43.27%1,352,7163,763,5754,364,5353,873,475
应收账款2,008,143-6.40%2,145,4312,409,6403,100,6083,576,798
存货602,4154.92%574,159752,5871,034,637995,815
其他流动资产667,76640.87%474,026141,027233,390502,375
4,045,769-11.01%4,546,3337,066,8298,733,1708,948,463

流动负债
短期借款336,796106.09%163,4250320,27197,182
应付票据4,608-88.12%38,79220,06332,65459,961
应付帐款1,274,375-4.13%1,329,2131,547,7131,772,4271,776,338
其他流动负债334,713-17.50%405,693802,2261,078,5551,575,310
1,950,4920.69%1,937,1232,370,0023,203,9073,508,791
流动资产净值2,095,276-19.70%2,609,2104,696,8265,529,2645,439,672
资产总额减流动负债8,549,388-15.63%10,133,46612,354,31012,384,96311,827,236

非流动负债
长期借款836,260341.16%189,560433,336434,896314,241
应付债券0--0000
其他非流动负债382,018-6.26%407,514413,109554,707523,199
1,218,278104.04%597,074846,445989,603837,440

总权益
    实收股本1,599,3490.00%1,599,3491,599,3491,607,3481,607,244
    储备项目5,381,517-23.36%7,021,6427,830,1957,741,9287,476,728
股东权益6,980,866-19.02%8,620,9919,429,5439,349,2769,083,972
非控股权益350,244-61.74%915,4012,078,3212,046,0841,905,823